SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-136006
Filing Date
2004-08-09
Accepted
2004-08-09 16:56:17
Documents
8
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT d10q.htm 10-Q 323840
2 DISTRIBUTION AND LICENSE AGREEMENT dex101.htm EX-10.1 209768
3 FIRST AMENDMENT TO DISTRIBUTION AND LICENSE AGREEMENT dex102.htm EX-10.2 18802
4 EXTENSION AND ADDITIONAL SPACE AGREEMENT dex103.htm EX-10.3 212887
5 LEASE AGREEMENT dex104.htm EX-10.4 372478
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9022
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9049
8 SECTION 906 CEO & CFO CERTIFICATION dex32.htm EX-32 6428
  Complete submission text file 0001193125-04-136006.txt   1164598
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23272 | Film No.: 04962020
SIC: 2836 Biological Products, (No Diagnostic Substances)